Skip to main content
Clinical Trials/NCT03447028
NCT03447028CompletedNot Applicable

A Novel Prognostic Risk Factor for Patients Undergoing Radical Prostatectomy: Triglyseride-Glucose (TyG) Index

Recep Tayyip Erdogan University Training and Research Hospital0 sites200 target enrollmentStarted: January 1, 2007Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
200
Primary Endpoint
Oncological outcomes

Study Overview

Brief Summary

We investigate the association between Triglyserid-Glucose(TyG) index and prostate cancer in patients undergoing radical prostatectomy.

Detailed Description

TyG index is calculated with special formula. Patients undergoing radical prostatectomy are divided two groups according to the cut-off level of 8.55 for TyG index.Groups were compared statistically in terms of oncological outcomes and survival.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Cross Sectional

Eligibility Criteria

Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients undergoing radical prostatectomy for prostate cancer

Exclusion Criteria

  • taking medicines for established diabetes and dyslipidaemia,
  • presence of endocrinological disease,
  • history of bariatric surgery,
  • missing data and patients with uncontrolled follow-up

Outcomes

Primary Outcomes

Oncological outcomes

Time Frame: 5 years

Effect of TyG index on oncological outcomes of Prostate cancer

Secondary Outcomes

  • Survival(5 years)

Investigators

Sponsor
Recep Tayyip Erdogan University Training and Research Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mustafa Ozan HORSANALI

Urologist

Recep Tayyip Erdogan University Training and Research Hospital

Similar Trials